Summary
For Year 2026-27, Astec Lifesciences reports the following shareholding: Total Promoters at 71.97%, Mutual Fund at 3.02%, Insurance at 0%, Foreign Institutional Investors at 0.03%, Domestic Institutional Investors at 0.31%, and Retail at 24.67%. This breakdown provides a quick snapshot of ownership distribution for Astec Lifesciences in 2026-27.
Astec Lifesciences FAQs
As of 05-2026, the promoter shareholding in Astec Lifesciences stands at 71.97% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Astec Lifesciences is 0.03% and 0.31% respectively.
The retail shareholding of the Astec Lifesciences is 24.67%.
Changes in shareholding patterns of Astec Lifesciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Astec Lifesciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Astec Lifesciences Associated Pages
